How Addiction Treatments Work: What Science Shows | NM

Understanding how addiction treatments work starts with recognizing that treatment has several targets. Medications may address withdrawal, cravings, or substance effects. Behavioral therapies address learned responses, coping, and motivation. These approaches can work together, while continued care helps connect changes in substance use with health, relationships, and daily responsibilities.

A treatment plan can contain several parts without those parts doing the same job. Relief from physical symptoms, for example, does not automatically resolve a learned response to stress. Better coping skills may not address every medical need. Understanding these differences can make medication questions in outpatient care more meaningful and explain why individual and group addiction counseling may be combined. Research supports multiple established treatments, but it does not identify one plan that fits everyone. Your substance use pattern, health, circumstances, and treatment goals all matter.

Written by Tim Francis, SUD Content Specialist.

Tim is a nonclinical author. This guide supports discussion with qualified professionals.

What does science explain about how addiction treatments work?

Addiction treatments work by addressing different parts of a substance use disorder, including physical symptoms, learned responses, motivation, and daily functioning. Understanding these targets helps you assess online recovery health claims and understand why individual and group counseling may be used together rather than treated as competing options.

The National Institute on Drug Abuse (NIDA) describes substance use disorders as chronic, treatable medical conditions. Treatment can help people stop or reduce substance use, prevent a return to use, reduce harmful consequences, and function better in their families and communities. Those are connected goals, but improvement in one area does not establish that every other need has been addressed.

A useful distinction is the difference between a treatment's mechanism and its results. A mechanism explains what an approach is intended to change, such as reducing cravings or strengthening coping responses. Evidence about results examines whether an approach helps people in practice. A convincing explanation of a mechanism is not, by itself, proof that a treatment works. Established care needs evidence beyond an appealing story about the brain.

Treatment also operates at different levels. Medication can affect biological processes related to substance use. Counseling can help someone recognize situations that prompt use and practice another response. Support for health and daily responsibilities addresses problems that may remain even after substance use changes. None of these levels makes the others unimportant.

For example, reducing a strong urge to use and learning how to handle an argument are different tasks. A treatment plan may need to address both. This is an illustration of how targets can fit together, not a prediction about any person's care.

NIDA's treatment and recovery explanation emphasizes matching treatment to a person's substance use and related medical, mental, and social needs. Scientific support therefore does not mean everyone receives an identical package. It means the parts of care have supported purposes and are selected and adjusted for the person receiving them.

Which addiction treatment targets involve withdrawal, cravings, and drug effects?

Withdrawal, cravings, and rewarding drug effects are related but separate treatment targets. Relieving one does not necessarily resolve the others. Their differences help explain medication questions in outpatient treatment and the role of continuing recovery work within an Intensive Outpatient Program (IOP) when that level of care fits.

These terms describe different experiences and processes:

• Withdrawal: physical or emotional symptoms after substance use stops or decreases.
• Craving: a strong desire or urge to use a substance.
• Rewarding effects: substance effects that can encourage repeated use.

According to NIDA's treatment overview, withdrawal may include physical discomfort, restlessness, sleep problems, anxiety, or depressed mood. The symptoms and medical needs differ across substances and people. Some treatments reduce particular withdrawal symptoms, which can make it easier to begin or remain engaged in care. That purpose is distinct from addressing the full pattern of a substance use disorder.

Cravings can also relate to situations associated with past use. NIDA identifies stress and cues such as people, places, things, and moods as important treatment concerns. This helps explain why a person may feel physically better yet still need support during a familiar stressful situation. Feeling better after withdrawal does not prove that cue-related urges or other recovery needs have ended.

Changing a substance's rewarding effects is another possible target. Some medications make substance use less appealing by blocking particular effects or creating an unpleasant response. Other medications help control withdrawal and cravings without using that same mechanism. These differences are why the general phrase addiction medication tells you less than the medicine's specific purpose.

Withdrawal can also require medical attention. The National Institute on Alcohol Abuse and Alcoholism (NIAAA) warns that suddenly stopping after prolonged heavy drinking can cause dangerous withdrawal. Seek medical help to plan care rather than using general information as a home-withdrawal plan. For a seizure, unconsciousness, severe breathing trouble, or immediate danger, call 911.

How do addiction medications act on different treatment targets?

Addiction medications can reduce withdrawal or cravings, change how rewarding substance use feels, or make alcohol use unpleasant. Their actions and approved uses differ, so one medicine cannot represent all medication treatment. Medication discussions in outpatient care belong within a broader plan, which may also include individual and group counseling.

Some medicines act on the same receptors involved in a substance's effects. Receptors are sites on cells where particular chemical signals act. NIDA explains that methadone and buprenorphine for opioid use disorder activate opioid receptors in ways that control withdrawal symptoms and cravings when taken as prescribed. Nicotine replacement therapy similarly acts on nicotine receptors. Sharing a receptor target does not make medically directed treatment equivalent to uncontrolled substance use.

Other medicines block receptors. SAMHSA describes naltrexone as a medication that blocks opioid receptors and the euphoric and sedating effects of opioids. It also has an approved role in alcohol use disorder treatment, where it can reduce alcohol cravings and consumption. Its different uses do not mean every formulation has the same approval or that it is appropriate for everyone.

Alcohol treatment provides two further examples. Acamprosate is thought to help restore the balance of brain signaling disrupted by chronic alcohol use. Its role concerns ongoing recovery rather than serving as a general withdrawal treatment. Disulfiram interferes with alcohol breakdown, causing an unpleasant reaction if alcohol is consumed. It does not reduce alcohol cravings or treat withdrawal.

These examples explain mechanisms, not how to select a medicine. Approved indications, other medications, current substance use, and health conditions affect clinical decisions. Even medicines with related treatment goals can have very different precautions. Starting, stopping, or switching them requires individualized medical guidance, not comparison by mechanism alone.

The SAMHSA treatment-options resource describes medication and behavioral therapies as complementary parts of care. Medication can address a biological obstacle while counseling addresses responses to stress, relationships, and choices. This does not mean medication is available for every disorder: NIDA reports that FDA-approved medications do not yet exist for stimulant or cannabis use disorders. Behavioral treatment remains relevant in those situations.

How do behavioral addiction treatments change learning, motivation, and responses?

Behavioral addiction treatments help people change responses to substance-related cues, strengthen motivation, and practice skills for difficult situations. Different therapies approach these tasks differently. Individual and group counseling provide different settings for therapeutic work, while measuring progress in IOP can help connect treatment goals with changes in daily life.

Cognitive behavioral therapy focuses on the relationship between thoughts, feelings, situations, and behavior. NIDA describes its purpose as helping people recognize, avoid, and cope with situations where they are more likely to use substances. The goal is more specific than thinking positively. Treatment helps a person identify a pattern and develop a response that does not depend on substance use.

For illustration, a stressful interaction may be linked with an expectation that substance use is the only way to get relief. Therapeutic work can examine that expectation and practice a different response. This example describes a treatment target, not a self-treatment exercise or a claim that a single coping skill resolves addiction.

Motivational enhancement approaches address readiness for change. NIDA explains that these treatments help strengthen motivation and support setting and maintaining goals. NIAAA describes work on the advantages and disadvantages of change, confidence, planning, and skills. Motivation is therefore something treatment can help develop. Uncertainty about change does not make a person undeserving of care or mean that treatment has nothing to offer.

Contingency management uses positive reinforcement. A defined positive consequence follows a specific treatment-related behavior, such as attending counseling or meeting a substance-use goal. This connects the behavior with a reason to repeat it. NIDA identifies contingency management as especially effective for stimulant addiction. Its mechanism is different from punishment, general praise, or expecting someone to rely on willpower alone.

Other approaches address relationships and support. Family therapy can work on influences connected with substance use and family functioning. Twelve-step facilitation helps people become involved in mutual-support groups. The professional therapy and the peer-led group are different activities, even when they share some themes.

These treatments do not all require the same format. A technique can have a particular purpose while being delivered individually or in a group. The format describes where and with whom the work happens; the therapeutic approach describes what that work is trying to change. Neither label alone explains the entire treatment plan.

Behavioral treatment can also complement medication. Reduced cravings may leave more room to engage in counseling, while counseling can help with situations a medicine does not resolve. Neither contribution makes the other less legitimate.

Why can addiction treatment support health and daily functioning beyond stopping drug use?

Addiction treatment can address health, relationships, and daily responsibilities because substance use disorders may affect each of these areas. Stopping use does not automatically resolve every consequence. Counseling for substance use recovery and an appropriate IOP treatment structure can support recovery work alongside a person's continuing life at home.

NIDA explains that effective treatment should address the person's broader needs. These may include medical and mental health concerns, family relationships, work, and social circumstances. The connection is practical: a plan focused on substance use alone can leave other important problems untreated. A broader plan does not mean every service must come from one organization.

Co-occurring conditions also deserve attention in their own right. NIDA identifies mental health disorders, chronic pain, HIV, and hepatitis C among conditions that may occur alongside substance use disorders. Its treatment overview supports treating co-occurring conditions together rather than treating them as unrelated problems. Addiction counseling is not a substitute for the medical care those conditions require.

Daily functioning gives treatment goals a concrete setting. Learning a response to stress matters partly because stress occurs during ordinary responsibilities. Work on communication matters because recovery happens within relationships. Better functioning is not proof that substance-related risks have disappeared, but it can be a meaningful part of what treatment is trying to support.

Peer support can add another kind of help. NIDA distinguishes mutual-help groups from professional treatment because they are peer-led rather than led by health professionals. They can offer connection and continuing support. Their value does not make them interchangeable with medical evaluation or professionally delivered therapy.

Choice describes its IOP in Albuquerque, NM, as including weekly group and individual therapy, education about substance use disorder, and recovery tools. It also lists peer support and medical-provider support. Those services provide context for discussing outpatient recovery care, not a promise that Choice provides treatment for every co-occurring condition or offers any particular medication.

Why might addiction treatment need continuing adjustment?

Addiction treatment may need adjustment because substance use, health needs, goals, and daily circumstances can change. Continuing care provides opportunities to respond to those changes. Looking at progress in IOP and revisiting medication questions during outpatient care are parts of an ongoing discussion, not signs that someone has failed.

NIDA states that a return to substance use does not mean treatment has failed. It indicates a need to discuss resuming treatment, modifying it, or trying another approach. This is different from saying a return to use is harmless or inevitable. Some people experience it, and it deserves a clinical response rather than blame.

Adjustment can concern several parts of a plan. A therapy may need to place more emphasis on a recurring trigger. A medical concern may need evaluation. A person's goals or living circumstances may have changed. These are reasons to reconsider the fit between treatment and present needs, rather than expecting an old plan to remain suitable indefinitely.

Progress can be considered across several supported treatment goals:

• Changes in substance use and related harms.
• Changes in cravings and ability to manage triggers.
• Participation in treatment and recovery support.
• Physical and mental health needs receiving attention.
• Functioning in family, work, and community life.

These areas do not always change at the same pace. A person might attend consistently while still struggling with cravings. Someone else might reduce use while a medical concern remains unresolved. Looking at several areas avoids treating one encouraging change as proof that care is no longer needed. It also avoids dismissing meaningful gains because another problem persists.

For alcohol use disorder, NIAAA emphasizes follow-up and the possibility of setbacks. Continued contact can help clinicians adjust care as needs change. There is no single treatment length that this general evidence establishes for every person. Continuing treatment is a clinical decision, not a measure of character, and needing more support does not erase earlier progress.

How do established addiction treatments differ from approaches still being researched?

Established addiction treatments have evidence supporting specific uses; investigational approaches are still being studied for particular questions. An interesting mechanism does not establish effectiveness or suitability. Evaluating online treatment claims and keeping medication discussions grounded in clinical care helps separate research possibilities from currently supported treatment decisions.

NIDA describes research on new medications, brain stimulation, immune-based approaches, and treatments involving psychedelic drugs. These projects investigate different targets. Their inclusion in a research program does not establish that every approach works, that it is approved for addiction treatment, or that it is available through a particular provider.

The distinction is often specific to the condition and use. An intervention can have an established role for one condition while being investigated for another. Evidence about a medication for one substance use disorder cannot automatically be transferred to a different disorder. Similarly, supervised research does not establish the benefits or safety of unsupervised exposure.

Scientific language can also make an unsupported claim sound settled. Descriptions such as resetting the brain or eliminating addiction may compress complex findings into a promise the evidence does not support. A proposed biological explanation is a starting point for investigation, not a guarantee of recovery.

Current evidence already supports meaningful treatment options, including medications for certain substance use disorders and several behavioral therapies. Research may expand those options. You do not have to treat an experimental possibility as established care, or assume that established treatment has nothing to offer because research continues.

Frequently asked questions about how addiction treatments work

Does addiction treatment cure addiction?

Addiction treatment can help people manage a substance use disorder and recover, but NIDA does not describe it as a cure. Treatment can reduce substance use and harmful consequences while improving daily functioning. Some people need continuing care or more than one treatment episode. Needing further support does not cancel earlier progress.

Do medications work the same way for every substance use disorder?

No. Medications have different actions and approved uses. Some reduce withdrawal or cravings, some block rewarding effects, and disulfiram creates an unpleasant reaction to alcohol. FDA-approved medications exist for certain disorders, but not all. A medication's role depends on the condition, formulation, medical circumstances, and individual clinical assessment.

Can behavioral treatment help when no medication is approved for a substance use disorder?

Yes. Behavioral therapies are established treatments for substance use disorders, including conditions without an FDA-approved medication. They can address coping, motivation, learned responses, and treatment participation. NIDA identifies contingency management as especially effective for stimulant addiction. The absence of an approved medication does not mean that no supported treatment exists.

Does receiving medication make recovery less genuine?

No. Medication is an evidence-based treatment option for certain substance use disorders, not a measure of someone's commitment or character. NIDA explains that prescribed treatment can control withdrawal and cravings and help restore balance in affected brain circuits. Recovery can include medication, behavioral treatment, and other support matched to the person's needs.

Does a treatment being researched mean it already works?

No. Research investigates questions that are not yet fully answered. An approach may have a plausible mechanism or encouraging early findings without an established addiction-treatment role. Evidence for another condition also does not prove benefit for a substance use disorder. Research participation and routine clinical treatment are different contexts.

Sources

• NIDA: Treatment and Recovery
• NIDA: Treatment research overview
• NIAAA: Treatment for Alcohol Problems
• SAMHSA: Treatment Options for Substance Use Disorder
• SAMHSA: Acamprosate
• SAMHSA: Disulfiram
• SAMHSA: Naltrexone
• Choice Recovery Path: Intensive Outpatient Program (IOP)
• Choice Recovery Path: Contact information

If you want to consider outpatient support, you can review Choice's IOP description or contact Choice Recovery Path to discuss your needs and current options. You do not need to have every treatment detail settled before beginning a conversation.